{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:15:54Z","timestamp":1791353754746,"version":"4.3.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.cytogfr.2008.11.007","type":"journal-article","created":{"date-parts":[[2008,11,29]],"date-time":"2008-11-29T11:04:10Z","timestamp":1227956650000},"page":"7-17","source":"Crossref","is-referenced-by-count":221,"title":["NF-\u03baB modulators in osteolytic bone diseases"],"prefix":"10.1016","volume":"20","author":[{"given":"Jiake","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua Fei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estabelle S.M.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalene","family":"Woloszyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming H.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren Xiang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2008.11.007_bib1","first-page":"1325","article-title":"Interaction between osteoblast and osteoclast: impact in bone disease","volume":"19","author":"Phan","year":"2004","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar1857","article-title":"Osteoclasts; culprits in inflammatory osteolysis","volume":"8","author":"Teitelbaum","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-kappaB: linking inflammation and immunity to cancer development and progression","volume":"5","author":"Karin","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd1279","article-title":"The IKK NF-kappa B system: a treasure trove for drug development","volume":"3","author":"Karin","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0092-8674(02)01166-2","article-title":"NF-kappaB signalling. Many roads lead to Madrid","volume":"111","author":"Dixit","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib8","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1359\/jbmr.2000.15.11.2178","article-title":"Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand","volume":"15","author":"Xu","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib11","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib12","doi-asserted-by":"crossref","first-page":"34120","DOI":"10.1074\/jbc.273.51.34120","article-title":"The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily","volume":"273","author":"Galibert","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib13","doi-asserted-by":"crossref","first-page":"20551","DOI":"10.1074\/jbc.273.32.20551","article-title":"Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase","volume":"273","author":"Darnay","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/MCB.18.1.558","article-title":"4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB","volume":"18","author":"Arch","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0092-8674(00)00126-4","article-title":"Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain","volume":"103","author":"Deng","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","article-title":"TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling","volume":"13","author":"Lomaga","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib17","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib18","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.20042081","article-title":"I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss","volume":"201","author":"Ruocco","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib19","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1101\/gad.14.7.854","article-title":"Severe liver degeneration and lack of NF-kappaB activation in NEMO\/IKKgamma-deficient mice","volume":"14","author":"Rudolph","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/376167a0","article-title":"Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B","volume":"376","author":"Beg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/JCI33392","article-title":"RelA\/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice","author":"Vaira","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib22","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/JBMR.040919","article-title":"Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity","volume":"19","author":"Yip","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib23","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1073\/pnas.0708576105","article-title":"RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation","volume":"105","author":"Vaira","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib24","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.93.8.3405","article-title":"Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor","volume":"93","author":"Gerondakis","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib25","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1128\/MCB.16.5.2341","article-title":"IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice","volume":"16","author":"Klement","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20030116","article-title":"The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis","volume":"198","author":"Novack","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib27","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1172\/JCI23763","article-title":"NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis","volume":"115","author":"Aya","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1534-5807(03)00403-9","article-title":"The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis","volume":"6","author":"Dur\u00e1n","year":"2004","journal-title":"Dev Cell"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/JCI34257","article-title":"Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice","author":"Jin","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib30","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1074\/jbc.271.9.4605","article-title":"Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells","volume":"271","author":"Jimi","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib31","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0883-5403(99)90074-8","article-title":"Primary total hip arthroplasty with a cementless porous-coated anatomic total hip prosthesis: 10\u201312-year results of prospective and consecutive series","volume":"14","author":"Kim","year":"1999","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0142-9612(01)00134-X","article-title":"Inflammatory responses to orthopaedic biomaterials in the murine air pouch","volume":"23","author":"Wooley","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib33","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1302\/0301-620X.85B6.12813","article-title":"Cement particles containing radio-opacifiers stimulate pro-osteolytic cytokine production from a human monocytic cell line","volume":"85","author":"Shardlow","year":"2003","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/rheumatology\/33.4.309","article-title":"Interleukin-1 production by activated macrophages surrounding loosened orthopaedic implants: a potential role in osteolysis","volume":"33","author":"al Saffar","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0142-9612(03)00556-8","article-title":"Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin","volume":"25","author":"Crotti","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib36","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0002-9440(10)64942-5","article-title":"Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation","volume":"156","author":"Huang","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib37","first-page":"1277","article-title":"Bone allograft non-union is related to excessive osteoclastic bone resorption: a sheep model study","volume":"21","author":"Laird","year":"2006","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2106\/00004623-199905000-00002","article-title":"Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro","volume":"81","author":"Nakashima","year":"1999","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib39","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0736-0266(01)00180-2","article-title":"The role of p105 protein in NFkappaB activation in ANA-1 murine macrophages following stimulation with titanium particles","volume":"20","author":"Soloviev","year":"2002","journal-title":"J Orthop Res"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/ar81","article-title":"Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis","volume":"2","author":"Schwarz","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00268158","article-title":"The deposition of immunoglobulins and complement in osteoarthritic cartilage","volume":"4","author":"Cooke","year":"1980","journal-title":"Int Orthop"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib42","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M","article-title":"Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis","volume":"43","author":"Bendele","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib43","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1357-4310(00)01757-3","article-title":"Cytokines in rheumatoid arthritis: trials and tribulations","volume":"6","author":"Carteron","year":"2000","journal-title":"Mol Med Today"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib44","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/1529-0131(200112)44:12<2937::AID-ART484>3.0.CO;2-G","article-title":"Effects of anti-tumor necrosis factor alpha on synovium in patients with spondylarthropathy: comment on the article by Baeten et al","volume":"44","author":"Cunnane","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03008209909005273","article-title":"The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models","volume":"40","author":"Goldring","year":"1999","journal-title":"Connect Tissue Res"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib46","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1471-4892(02)00165-0","article-title":"Small-molecule inhibitors of NF-kappaB for the treatment of inflammatory joint disease","volume":"2","author":"Roshak","year":"2002","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib47","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/art.1780381209","article-title":"Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65","volume":"38","author":"Handel","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib48","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/art.1780390407","article-title":"Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue","volume":"39","author":"Marok","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/art.1780390205","article-title":"Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha","volume":"39","author":"Fujisawa","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib50","doi-asserted-by":"crossref","first-page":"37219","DOI":"10.1074\/jbc.C400258200","article-title":"The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis","volume":"279","author":"Dai","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib51","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.4049\/jimmunol.166.4.2705","article-title":"NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes","volume":"166","author":"Aupperle","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib52","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0022-3565(24)37907-8","article-title":"Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells","volume":"287","author":"Han","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/clin.1997.4333","article-title":"The effect of dexamethasone on the expression of activated NF-kappa B in adjuvant arthritis","volume":"83","author":"Tsao","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib54","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4","article-title":"Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation","volume":"44","author":"Tak","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib55","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nm1054","article-title":"Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo","volume":"10","author":"Jimi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib56","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1016\/S8756-3282(99)00045-9","article-title":"Mechanisms of abnormal bone turnover in Paget's disease","volume":"24","author":"Roodman","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib57","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/340731","article-title":"Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1\/p62) in Paget disease of bone","volume":"70","author":"Laurin","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib58","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/hmg\/11.22.2735","article-title":"Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease","volume":"11","author":"Hocking","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib59","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1359\/JBMR.040203","article-title":"Two novel mutations at exon 8 of the Sequestosome 1 (SQSTM1) gene in an Italian series of patients affected by Paget's disease of bone (PDB)","volume":"19","author":"Falchetti","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2353\/ajpath.2006.050960","article-title":"p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone","volume":"169","author":"Yip","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib61","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1359\/jbmr.060405","article-title":"A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype","volume":"21","author":"Rea","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib62","first-page":"17","article-title":"Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction","volume":"11","author":"Liu","year":"2003","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib63","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1902\/jop.2004.75.12.1586","article-title":"Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients","volume":"75","author":"Vernal","year":"2004","journal-title":"J Periodontol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2249.2007.03342.x","article-title":"Differential activation of NF-kappaB and gene expression in oral epithelial cells by periodontal pathogens","volume":"148","author":"Milward","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib65","doi-asserted-by":"crossref","first-page":"31142","DOI":"10.1074\/jbc.M603417200","article-title":"A dominant function of IKK\/NF-kappaB signaling in global lipopolysaccharide-induced gene expression","volume":"281","author":"Carayol","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib66","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.febslet.2005.12.079","article-title":"Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition","volume":"580","author":"Nakajima","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib67","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jcp.20127","article-title":"TNF-alpha expression is transcriptionally regulated by RANK ligand","volume":"202","author":"Zou","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib68","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.4049\/jimmunol.172.10.5940","article-title":"Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis","volume":"172","author":"Bharti","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib69","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1074\/jbc.M410764200","article-title":"P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts","volume":"280","author":"Korcok","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib70","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.4049\/jimmunol.176.5.3127","article-title":"Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression","volume":"176","author":"Takada","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib71","doi-asserted-by":"crossref","first-page":"9555","DOI":"10.1158\/0008-5472.CAN-05-1585","article-title":"N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products","volume":"65","author":"Shishodia","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib72","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1158\/1535-7163.MCT-06-0096","article-title":"Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression","volume":"5","author":"Ichikawa","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib73","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jcp.21188","article-title":"Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid","volume":"214","author":"Rahman","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib74","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/1541-7786.MCR-06-0076","article-title":"Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway","volume":"4","author":"Ahn","year":"2006","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib75","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2007-04-084996","article-title":"Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-kappaB regulated gene products","volume":"110","author":"Ahn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib76","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1074\/jbc.M507213200","article-title":"Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation","volume":"281","author":"Takada","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib77","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jbmr.5650110106","article-title":"Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group","volume":"11","author":"Bauer","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib79","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/009127009803801101","article-title":"Nuclear factor kappa B: important transcription factor and therapeutic target","volume":"38","author":"Lee","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib80","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jcp.20159","article-title":"Evidence of reciprocal regulation between the high extracellular calcium and RANKL signal transduction pathways in RAW cell derived osteoclasts","volume":"202","author":"Xu","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib81","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1359\/JBMR.050324","article-title":"Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production","volume":"20","author":"Yip","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cytogfr.2008.11.007_bib82","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1359\/jbmr.2003.18.12.2159","article-title":"12-O-Tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation","volume":"18","author":"Wang","year":"2003","journal-title":"J Bone Miner Res"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610108000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610108000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:50:55Z","timestamp":1738713055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610108000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1359610108000713"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2008.11.007","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}